DOR/TDF/3TC Switch With M184V/I in People With Controlled HIV (Drive Off-Road)

Abroad (travel likely)RecruitingPHASE2

Conditions

Hiv

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CHU de Caen, Caen, France
Contact: Study coordinator (Renaud Verdon, MD, PhD)
Study coordinator · +33 231064320
CHU Orléans, Orléans, France
Contact: Study coordinator (Laurent Hocqueloux, MD)
Study coordinator · +33238514444
CHU Rouen, Rouen, France
Contact: Study coordinator (Manuel Etienne, MD, PhD) · +33 232888990
CH Tourcoing, Tourcoing, France
Contact: Study coordinator (Olivier Robineau) · +33 320694949

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)

Human Immunodeficiency Virus (HIV) Infection

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Atlanta, United States

Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV

Human Papilloma Virus · Anal Dysplasia · HIV

Abroad (travel likely)RecruitingPHASE2

Washington D.C., United States · Baltimore, United States

Leukapheresis Procedures to Obtain Plasma and Lymphocytes for Research Studies on Antiretroviral Naive HIV-1 Research Participants

HIV

Abroad (travel likely)Recruiting

Bethesda, United States

Cabotegravir-Hormone PK/PD Interactions for HIV Prevention

HIV · Prophylaxis · Injectable

Abroad (travel likely)RecruitingPHASE1

Baltimore, United States